Literature DB >> 31021272

Classification and Nomenclature of CRISPR-Cas Systems: Where from Here?

Kira S Makarova1, Yuri I Wolf1, Eugene V Koonin1.   

Abstract

As befits an immune mechanism, CRISPR-Cas systems are highly variable with respect to Cas protein sequences, gene composition, and organization of the genomic loci. Optimal classification of CRISPR-Cas systems and rational nomenclature for CRISPR-associated genes are essential for further progress of CRISPR research. These are highly challenging tasks because of the complexity of CRISPR-Cas and their fast evolution, including frequent module shuffling, as well as the lack of universal markers for a consistent evolutionary classification. The complexity and variability of CRISPR-Cas systems necessitate a multipronged approach to classification and nomenclature. We present a brief summary of the current state of the art and discuss further directions in this area.

Year:  2018        PMID: 31021272      PMCID: PMC6636873          DOI: 10.1089/crispr.2018.0033

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  71 in total

1.  Structural basis of Type IV CRISPR RNA biogenesis by a Cas6 endoribonuclease.

Authors:  Hannah N Taylor; Emily E Warner; Matthew J Armbrust; Valerie M Crowley; Keith J Olsen; Ryan N Jackson
Journal:  RNA Biol       Date:  2019-06-28       Impact factor: 4.652

2.  Nonspecific toxicities of Streptococcus pyogenes and Staphylococcus aureus dCas9 in Chlamydia trachomatis.

Authors:  Wurihan Wurihan; Yehong Huang; Alec M Weber; Xiang Wu; Huizhou Fan
Journal:  Pathog Dis       Date:  2019-12-01       Impact factor: 3.166

3.  A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.

Authors:  Lucia M Malone; Suzanne L Warring; Simon A Jackson; Carolin Warnecke; Paul P Gardner; Laura F Gumy; Peter C Fineran
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

4.  A Type IV-A CRISPR-Cas System in Pseudomonas aeruginosa Mediates RNA-Guided Plasmid Interference In Vivo.

Authors:  Valerie M Crowley; Adam Catching; Hannah N Taylor; Adair L Borges; Josie Metcalf; Joseph Bondy-Denomy; Ryan N Jackson
Journal:  CRISPR J       Date:  2019-11-27

Review 5.  Correction of muscular dystrophies by CRISPR gene editing.

Authors:  Francesco Chemello; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system.

Authors:  Kakimani Nagarajan Yoganand; Manasasri Muralidharan; Siddharth Nimkar; Baskaran Anand
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

7.  Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus.

Authors:  Claudio Hidalgo-Cantabrana; Yong Jun Goh; Meichen Pan; Rosemary Sanozky-Dawes; Rodolphe Barrangou
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-24       Impact factor: 11.205

8.  Casposase structure and the mechanistic link between DNA transposition and spacer acquisition by CRISPR-Cas.

Authors:  Alison B Hickman; Shweta Kailasan; Pavol Genzor; Astrid D Haase; Fred Dyda
Journal:  Elife       Date:  2020-01-08       Impact factor: 8.140

9.  Predicted highly derived class 1 CRISPR-Cas system in Haloarchaea containing diverged Cas5 and Cas7 homologs but no CRISPR array.

Authors:  Kira S Makarova; Svetlana Karamycheva; Shiraz A Shah; Gisle Vestergaard; Roger A Garrett; Eugene V Koonin
Journal:  FEMS Microbiol Lett       Date:  2019-04-01       Impact factor: 2.742

10.  CRISPR-Cas in mobile genetic elements: counter-defence and beyond.

Authors:  Guilhem Faure; Sergey A Shmakov; Winston X Yan; David R Cheng; David A Scott; Joseph E Peters; Kira S Makarova; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2019-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.